Table of Content




1. Executive Summary


2. Global Radiopharmaceutical Theranostics Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 


3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Radiopharmaceutical Theranostics Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Radiopharmaceutical Theranostics Market by Product Type
3.3.1: Alpha Emitters
3.3.2: Beta Emitters
3.3.3: PET Tracers

3.4: Global Radiopharmaceutical Theranostics Market by Source
3.4.1: Nuclear Reactors
3.4.2: Cyclotrons

3.5: Global Radiopharmaceutical Theranostics Market by Indication
3.5.1: Oncology
3.5.2: Cardiology
3.5.3: Neurology
3.5.4: Others


3.6: Global Radiopharmaceutical Theranostics Market by End Use
3.6.1: Hospitals
3.6.2: Diagnostic Imaging Centers
3.6.3: Academic & Research Institutes
3.6.4: Others


4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Radiopharmaceutical Theranostics Market by Region
4.2: North American Radiopharmaceutical Theranostics Market
4.2.2: North American Radiopharmaceutical Theranostics Market by End Use: Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, and Others


4.3: European Radiopharmaceutical Theranostics Market
4.3.1: European Radiopharmaceutical Theranostics Market by Product Type: Alpha Emitters, Beta Emitters, and PET Tracers
4.3.2: European Radiopharmaceutical Theranostics Market by End Use: Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, and Others


4.4: APAC Radiopharmaceutical Theranostics Market
4.4.1: APAC Radiopharmaceutical Theranostics Market by Product Type: Alpha Emitters, Beta Emitters, and PET Tracers
4.4.2: APAC Radiopharmaceutical Theranostics Market by End Use: Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, and Others


4.5: ROW Radiopharmaceutical Theranostics Market
4.5.1: ROW Radiopharmaceutical Theranostics Market by Product Type: Alpha Emitters, Beta Emitters, and PET Tracers
4.5.2: ROW Radiopharmaceutical Theranostics Market by End Use: Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, and Others



5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis


6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Radiopharmaceutical Theranostics Market by Product Type
6.1.2: Growth Opportunities for the Global Radiopharmaceutical Theranostics Market by Source
6.1.3: Growth Opportunities for the Global Radiopharmaceutical Theranostics Market by Indication
6.1.4: Growth Opportunities for the Global Radiopharmaceutical Theranostics Market by End Use
6.1.5: Growth Opportunities for the Global Radiopharmaceutical Theranostics Market by Region

6.2: Emerging Trends in the Global Radiopharmaceutical Theranostics Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Radiopharmaceutical Theranostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Radiopharmaceutical Theranostics Market
6.3.4: Certification and Licensing


7. Company Profiles of Leading Players
7.1: Bayer
7.2: GE HealthCare Technologies
7.3: Curium
7.4: Lantheus Medical Imaging
7.5: Telix Pharmaceuticals
7.6: Cardinal Health
7.7: Advanced Accelerator Applications
7.8: Jubilant Radiopharma
7.9: Theragnostics
7.10: NuView Life Sciences